Cargando…
Major Neurologic Adverse Drug Reactions, Potential Drug–Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review
Stroke has been considered as one of the underlying diseases that increases the probability of severe infection and mortality. Meanwhile, there are ongoing reports of stroke subsequent to COVID-19 infection. In this narrative paper, we reviewed major neurologic adverse drug reactions (ADRs) and phar...
Autores principales: | Ghasemiyeh, Parisa, Borhani-Haghighi, Afshin, Karimzadeh, Iman, Mohammadi-Samani, Soliman, Vazin, Afsaneh, Safari, Anahid, Qureshi, Adnan I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335700/ https://www.ncbi.nlm.nih.gov/pubmed/32669846 http://dx.doi.org/10.2147/TCRM.S259152 |
Ejemplares similares
-
Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications
por: Ghasemiyeh, Parisa, et al.
Publicado: (2021) -
COVID-19 outbreak: Challenges in pharmacotherapy based on pharmacokinetic and pharmacodynamic aspects of drug therapy in patients with moderate to severe infection
por: Ghasemiyeh, Parisa, et al.
Publicado: (2020) -
A simple and validated HPLC method for vancomycin assay in plasma samples: the necessity of TDM center development in Southern Iran
por: Ghasemiyeh, Parisa, et al.
Publicado: (2020) -
Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters
por: Ghasemiyeh, Parisa, et al.
Publicado: (2022) -
Volume of distribution as an early predictor of vancomycin-induced AKI in critically ill patients
por: Ghasemiyeh, Parisa, et al.
Publicado: (2023)